[HTML][HTML] A European model for an organised risk-stratified early detection programme for prostate cancer
H Van Poppel, R Hogenhout, P Albers… - European urology …, 2021 - Elsevier
Context Overdiagnosis as the argument to stop prostate cancer (PCa) screening is less valid
since the introduction of new technologies such as risk calculators (RCs) and magnetic …
since the introduction of new technologies such as risk calculators (RCs) and magnetic …
Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis
Q Wu, X Tu, C Zhang, J Ye, T Lin, Z Liu… - Prostate Cancer and …, 2024 - nature.com
Purpose Magnetic resonance imaging (MRI) has deeply altered the prostate biopsy strategy
to detect prostate cancer. However, it is still debatable whether the detection rate differs …
to detect prostate cancer. However, it is still debatable whether the detection rate differs …
Is there an impact of transperineal versus transrectal magnetic resonance imaging–targeted biopsy in clinically significant prostate cancer detection rate? A systematic …
A Uleri, M Baboudjian, A Tedde, A Gallioli… - European Urology …, 2023 - Elsevier
Context It is unclear whether a magnetic resonance imaging (MRI)-targeted transperineal
(TP) biopsy can improve the detection of clinically significant prostate cancer (csPCa) …
(TP) biopsy can improve the detection of clinically significant prostate cancer (csPCa) …
The detection of prostate cancer with magnetic resonance imaging-targeted prostate biopsies is superior with the transperineal vs the transrectal approach. A …
F Zattoni, G Marra, V Kasivisvanathan… - The Journal of …, 2022 - auajournals.org
Purpose: Our aim was to evaluate whether transperineal (TP) MRI-targeted prostate biopsy
(TBx) may improve the detection of clinically significant prostate cancer (csPCa), defined as …
(TBx) may improve the detection of clinically significant prostate cancer (csPCa), defined as …
French AFU Cancer Committee Guidelines-Update 2022-2024: prostate cancer-Diagnosis and management of localised disease
G Ploussard, G Fiard, E Barret, L Brureau… - Progrès en Urologie, 2022 - Elsevier
Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …
an update of the recommendations for the diagnosis and management of prostate cancer …
[HTML][HTML] Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 2: interpretation
Background There is large variability among radiologists in their detection of clinically
significant (cs) prostate cancer (PCa) on multiparametric magnetic resonance imaging …
significant (cs) prostate cancer (PCa) on multiparametric magnetic resonance imaging …
The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates
R Hogenhout, S Remmers… - Prostate Cancer and …, 2023 - nature.com
Background Currently, transperineal prostate biopsy (TPB) is preferred over transrectal
biopsy (TRB) because of less infectious complications and improved clinically significant …
biopsy (TRB) because of less infectious complications and improved clinically significant …
[HTML][HTML] Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 4: transperineal …
J Immerzeel, B Israël, J Bomers, IG Schoots… - European Urology, 2022 - Elsevier
Background Transperineal magnetic resonance imaging–transrectal ultrasound fusion
guided biopsy (MFGB) is an increasingly popular technique due to increasing rates of …
guided biopsy (MFGB) is an increasingly popular technique due to increasing rates of …
[HTML][HTML] Shifting to transperineal prostate biopsy: A narrative review
Y Chung, SK Hong - Prostate International, 2023 - Elsevier
Objective To address the limitations and challenges associated with transrectal (TR) biopsy
and to present transperineal (TP) biopsy as a viable and potentially safer alternative to TR …
and to present transperineal (TP) biopsy as a viable and potentially safer alternative to TR …
Transperineal versus transrectal magnetic resonance imaging–targeted biopsies for prostate cancer diagnosis: final results of the randomized PERFECT trial (CCAFU …
Background Recent guidelines favor transperineal (TP) prostate biopsies over the
transrectal (TR) approach due to a reduced sepsis risk. Yet, evidence from controlled trial …
transrectal (TR) approach due to a reduced sepsis risk. Yet, evidence from controlled trial …